top of page

Revolutionizing the
Clinical Management
of Aneurysm Patients


AI-Backed Clinical Decision Making

Aneurysm Rupture is Often Fatal

An abdominal aortic aneurysm (AAA) is a ballooning of the aorta that will continue to grow. There are 200,000 diagnoses annually in the United States. Clinicians still use the outdated one-size-fits-all maximum diameter criterion to decide when to intervene. If the patients are below the threshold (5.0 cm for women and 5.5 cm for men), they will be monitored until they are offered surgical intervention. However, it has been reported that between 7-23.4% of aneurysms can rupture before this threshold, making AAA rupture the 13th leading cause of death in the United States.

Aneurisk Inc. is focused on changing the clinical management of aneurysms with artificial intelligence. Our team has developed an automated pipeline that utilizes medical images and patient clinical data to provide a comprehensive view of a patient's aneurysm to improve outcomes. Our clinical decision support tool could reduce surveillance intervals for imaging, reduce rupture events, identify high-risk aneurysms, and reduce unnecessary surgery.

Wall stress analysis of adominal aortic aneursym


Tim Chung

Timothy K. Chung, PhD

Chief Technology Officer

Assistant Professor of Bioengineering


  • LinkedIn
Dr. Nathan Liang

Nathan L. Liang, MD, MS

Chief Executive/Medical Officer 
Assistant Professor of Surgery

  • LinkedIn

David A. Vorp, PhD

Chief Scientific Officer 
Professor of Bioengineering

Dr. David Vorp
  • LinkedIn

Funding Agencies and Awards

Pittsburgh Health Data Alliance

$300K (2020)

National Institutes of Health

$236K (2021)

Institute for Precision Medicine

$100K (2021)

Lifex Labs


National Science Foundation

$50K (2023)

bottom of page